Citadel Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $125M | Buy |
1,378,665
+1,050,289
| +320% | +$96.4M | 0.02% | 676 |
|
|
2025
Q4 | $29.5M | Buy |
328,376
+212,230
| +183% | +$20.1M | ﹤0.01% | 1927 |
|
|
2025
Q3 | $11.4M | Buy |
+116,146
| New | +$11.5M | ﹤0.01% | 3075 |
|
|
2025
Q2 | – | Sell |
-2,042,564
| Closed | -$198M | – | 15445 |
|
|
2025
Q1 | $231M | Sell |
2,042,564
-363,556
| -15% | -$38.9M | 0.04% | 328 |
|
|
2024
Q4 | $254M | Buy |
2,406,120
+1,921,342
| +396% | +$206M | 0.04% | 313 |
|
|
2024
Q3 | $52.3M | Buy |
484,778
+108,295
| +29% | +$11.8M | 0.01% | 1170 |
|
|
2024
Q2 | $40.9M | Sell |
376,483
-348,834
| -48% | -$41.1M | 0.01% | 1313 |
|
|
2024
Q1 | $95.7M | Buy |
725,317
+121,769
| +20% | +$15.2M | 0.02% | 725 |
|
|
2023
Q4 | $73.5M | Sell |
603,548
-918,153
| -60% | -$102M | 0.01% | 885 |
|
|
2023
Q3 | $171M | Buy |
1,521,701
+1,455,618
| +2,203% | +$185M | 0.04% | 372 |
|
|
2023
Q2 | $9.62M | Buy |
66,083
+62,759
| +1,888% | +$8.53M | ﹤0.01% | 2730 |
|
|
2023
Q1 | $429K | Sell |
3,324
-2,328,300
| -100% | -$292M | ﹤0.01% | 8616 |
|
|
2022
Q4 | $297M | Buy |
2,331,624
+129,819
| +6% | +$15.1M | 0.07% | 207 |
|
|
2022
Q3 | $230M | Buy |
2,201,805
+2,159,222
| +5,071% | +$237M | 0.05% | 260 |
|
|
2022
Q2 | $4.47M | Buy |
+42,583
| New | +$5.05M | ﹤0.01% | 4015 |
|
|
2022
Q1 | – | Sell |
-107,280
| Closed | -$12.9M | – | 14730 |
|
|
2021
Q4 | $13.2M | Sell |
107,280
-388,057
| -78% | -$50.8M | ﹤0.01% | 2608 |
|
|
2021
Q3 | $70.4M | Buy |
495,337
+477,289
| +2,645% | +$70.2M | 0.01% | 877 |
|
|
2021
Q2 | $2.82M | Sell |
18,048
-1,282,370
| -99% | -$208M | ﹤0.01% | 5752 |
|
|
2021
Q1 | $202M | Sell |
1,300,418
-361,823
| -22% | -$56M | 0.05% | 281 |
|
|
2020
Q4 | $249M | Buy |
1,662,241
+867,560
| +109% | +$123M | 0.06% | 189 |
|
|
2020
Q3 | $105M | Sell |
794,681
-74,189
| -9% | -$9.69M | 0.03% | 439 |
|
|
2020
Q2 | $101M | Buy |
868,870
+828,079
| +2,030% | +$95.4M | 0.04% | 406 |
|
|
2020
Q1 | $4M | Sell |
40,791
-205,559
| -83% | -$26.9M | ﹤0.01% | 3029 |
|
|
2019
Q4 | $35.8M | Sell |
246,350
-702,144
| -74% | -$96.9M | 0.02% | 995 |
|
|
2019
Q3 | $126M | Buy |
948,494
+472,845
| +99% | +$61.1M | 0.06% | 296 |
|
|
2019
Q2 | $54.4M | Sell |
475,649
-1,172,960
| -71% | -$137M | 0.02% | 678 |
|
|
2019
Q1 | $204M | Buy |
1,648,609
+1,645,020
| +45,835% | +$187M | 0.1% | 140 |
|
|
2018
Q4 | $361K | Sell |
3,589
-216,139
| -98% | -$24.3M | ﹤0.01% | 6946 |
|
|
2018
Q3 | $28M | Buy |
+219,728
| New | +$26.1M | 0.01% | 1129 |
|
|
2018
Q2 | – | Sell |
-8,892
| Closed | -$968K | – | 9365 |
|
|
2018
Q1 | $941K | Sell |
8,892
-72,972
| -89% | -$8.47M | ﹤0.01% | 4910 |
|
|
2017
Q4 | $9.59M | Sell |
81,864
-247,415
| -75% | -$28M | 0.01% | 1780 |
|
|
2017
Q3 | $37.4M | Sell |
329,279
-752,022
| -70% | -$86.8M | 0.03% | 702 |
|
|
2017
Q2 | $135M | Sell |
1,081,301
-264,293
| -20% | -$31.3M | 0.11% | 154 |
|
|
2017
Q1 | $160M | Buy |
1,345,594
+835,299
| +164% | +$94.7M | 0.15% | 106 |
|
|
2016
Q4 | $51.1M | Sell |
510,295
-449,622
| -47% | -$48.2M | 0.05% | 379 |
|
|
2016
Q3 | $121M | Buy |
959,917
+475,286
| +98% | +$58.7M | 0.12% | 119 |
|
|
2016
Q2 | $56.6M | Buy |
484,631
+200,991
| +71% | +$22.7M | 0.06% | 294 |
|
|
2016
Q1 | $29.4M | Sell |
283,640
-308,344
| -52% | -$29.8M | 0.04% | 538 |
|
|
2015
Q4 | $59M | Buy |
591,984
+527,543
| +819% | +$51.6M | 0.06% | 330 |
|
|
2015
Q3 | $5.88M | Sell |
64,441
-575,947
| -90% | -$57.7M | 0.01% | 1784 |
|
|
2015
Q2 | $67.9M | Sell |
640,388
-396,032
| -38% | -$43.8M | 0.06% | 365 |
|
|
2015
Q1 | $118M | Buy |
1,036,420
+943,792
| +1,019% | +$108M | 0.11% | 182 |
|
|
2014
Q4 | $10.2M | Sell |
92,628
-34,997
| -27% | -$3.69M | 0.01% | 1386 |
|
|
2014
Q3 | $12.5M | Sell |
127,625
-781,561
| -86% | -$76.9M | 0.01% | 1214 |
|
|
2014
Q2 | $91.7M | Buy |
909,186
+740,388
| +439% | +$72.2M | 0.11% | 184 |
|
|
2014
Q1 | $15.5M | Buy |
168,798
+150,341
| +815% | +$13.9M | 0.02% | 992 |
|
|
2013
Q4 | $1.67M | Sell |
18,457
-419,889
| -96% | -$36.3M | ﹤0.01% | 2722 |
|
|
2013
Q3 | $35M | Buy |
438,346
+353,616
| +417% | +$27.8M | 0.05% | 452 |
|
|
2013
Q2 | $6.16M | Buy |
+84,730
| New | +$6.34M | 0.01% | 1377 |
|
Other funds holding ZBH
VCM
VPM
Citadel Advisors's ZBH Position: Q1 2026 in Review
Citadel Advisors increased its Zimmer Biomet (ZBH) stake by 320% in Q1 2026, buying an estimated $96.4M and bringing the position to 1,378,665 shares worth $125M. The position accounts for 0.02% of the portfolio, ranked #676.
Citadel Advisors first reported a position in ZBH in Q2 2013 and has held it in 49 quarters since. The position peaked at $297M in Q4 2022. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Citadel Advisors held 1,378,665 shares of Zimmer Biomet worth $125M as of Q1 2026.
- Citadel Advisors bought 1,050,289 Zimmer Biomet shares in Q1 2026, an estimated $96.4M.
- Zimmer Biomet made up 0.02% of Citadel Advisors's portfolio in Q1 2026, its #676 holding.
- Citadel Advisors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 49 quarters since.
- Citadel Advisors's Zimmer Biomet position peaked at $297M in Q4 2022.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.